FeliciaCosmanMD
Endocrinology • West Haverstraw, NYDiabetes, Lipid Metabolism
Professor of Medicine, Columbia P&S
Dr. Cosman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
51 S Route 9w
Helen Hayes Hospital
West Haverstraw, NY 10993Phone+1 845-786-4494Fax+1 845-787-4878
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1983 - 1988
Stony Brook University Health Sciences Center School of MedicineClass of 1983
Certifications & Licensure
NY State Medical License 1985 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- Hudson Valley Magazine Castle Connolly, 2007-2013
- New York Magazine: Top Doctors Castle Connolly, 2002
Clinical Trials
- Parathyroid Hormone (PTH) With Alendronate for Osteoporosis Start of enrollment: 1987 Sep 01
- Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur Start of enrollment: 2010 Aug 01
- The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- Comparative Effectiveness of Abaloparatide and Teriparatide in Women 50 Years of Age and Older: Update of a Real-World Retrospective Analysis.Laila Tabatabai, Felicia Cosman, Jeffrey R Curtis, Kristi T DeSapri, Clayton T LaBaume
Endocrine Practice. 2024-11-16 - 2 citationsGoal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024.Felicia Cosman, E Michael Lewiecki, Richard Eastell, Peter R Ebeling, Suzanne Jan De Beur
Journal of Bone and Mineral Research. 2024-09-26 - 1 citationsRomosozumab followed by denosumab versus denosumab only: a post hoc analysis of FRAME and FRAME extension.Felicia Cosman, Mary Oates, Donald Betah, Jen Timoshanko, Zhenxun Wang
Journal of Bone and Mineral Research. 2024-09-02
Authored Content
- Abaloparatide: An Anabolic Treatment to Reduce Fracture Risk in Postmenopausal Women with OsteoporosisOctober 2020
Press Mentions
Highlights from the ACR Review Course 2022December 6th, 2022- Conference aids2022 HighlightsOctober 27th, 2022
- ACR 2020: 100+ Arthritis and Rheumatic Disease Updates Patients Must Know AboutNovember 25th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
